Z.Matijasevic et al.
could be repaired by mechanisms other than NER in the NER-
deficient cells, but the lack of a shoulder on the curve for
NER-deficient cells at low concentrations of damaging agent
suggests that NER is needed to restore full expression. In any
case, the data in Figure 5 indicate that the host cell reactivation
assay can be used to examine repair of SM- or CEES-induced
DNA damage within the cell. It is also apparent from the right
hand panel of Figure 5 that NER removes the monofunctional
adducts caused by CEES and, by analogy, the monofunctional
adducts caused by SM as well.
References
1.IARC (1987) IARC Monographs on the evaluation of carcinogenic risks
to humans: Overall evaluations of carcinogenicity: An updating of IARC
Monographs Volumes 1 to 42 (suppl. 7). IARC, Lyon, pp. 259–260.
2.Papirmeister,B., Feister,A.J., Robinson,S.I. and Ford,R.D. (1991) Medical
Defense Against Mustard Gas: Toxic Mechanisms and Pharmacological
Implications. CRC Press, Boca Raton.
3.Lawley,P.D. and Brookes,P. (1965) Molecular mechanism of the cytotoxic
action of difunctional alkylating agents and of resistance to this action.
Nature, 206, 480–483.
4.Masta,A., Gray,P.J. and Phillips,D.R. (1996) Effect of sulphur mustard on
the initiation and elongation of transcription. Carcinogenesis, 17, 525–532.
5.Roberts,J.J., Brent,T.P. and Crathorn,A.R. (1968) The mechanism of the
cytotoxic action of alkylating agents on mammalian cells: inactivation of
the DNA template and its repair. In Campbell,P.N. (ed.) The Interaction
of Drugs and Subcellular Components in Animal Cells. J. & A. Churchill,
London, WI.
6.Venitt,S. (1968) Interstrand cross-links in the DNA of Escherichia coli B/
r and BS–1 and their removal by the resistant strain. Biochem. Biophys.
Res. Commun., 31, 355–360.
7.Ball,C.R. and Roberts,J.J. (1970) DNA repair after mustard gas alkylation
by sensitive and resistant Yoshida sarcoma cells in vitro. Chem. Biol.
Interact., 2, 321–329.
8.Crathorn,A.R. and Roberts,J.J. (1966) Mechanism of the cytotoxic action
of alkylating agents in mammalian cells and evidence for the removal of
alkylated groups from deoxyribonucleic acid. Nature, 211, 150–153.
9.Roberts,J.J., Crathorn,A.R. and Brent,T.P. (1968) Repair of alkylated DNA
in mammalian cells. Nature, 218, 970–972.
10.Papirmeister,B. and Davison,C.L. (1964) Elimination of sulfur mustard-
induced products from DNA of Escherichia coli. Biochem. Biophys. Res.
Commun., 17, 608–617.
11.Reid,B.D. and Walker,I.G. (1969) The response of mammalian cells to
alkylating agents II. On the mechanism of the removal of sulfur-mustard-
induced cross-links. Biochim. Biophys. Acta, 179, 179–188.
12.Mol,M.A.E., van der Schans,G.P. and Lohman,H.M. (1993) Quantification
of sulfur mustard-induced DNA interstrand cross-links and single-strand
breaks in cultured human epidermal keratinocytes. Mutat. Res., 294,
235–245.
Discussion
The survival curves in Figure 2 show that the difunctional
agent SM is ~10-fold more cytotoxic than CEES for both cell
lines, in agreement with previous observations (2). Since CEES
forms monofunctional adducts that are similar to those formed
by SM, this difference in cytotoxicity between SM and CEES
has been assumed to be the result of cross-link formation (2).
The data (Figure 2, left panel) show that NER competent cells
are more resistant to the cytotoxic action of SM than are NER
deficient cells suggesting that the cytotoxic cross-link is
removed by the NER repair mechanism. Again, this would
agree with previous observations that the NER pathway recog-
nizes bulky adducts like DNA cross-links.
Since the data (Figure 2, right panel) show that NER
competent cells are also more resistant to the cytotoxic action
of CEES, we can conclude that NER repairs the monoadducts
formed by CEES and, presumably, the similar monoadducts
formed by SM as well. These adducts, as well as the cross-
link, would probably be classified as bulky because of the size
of their adducted groups.
Host cell reactivation data provide direct information on
cellular repair of DNA damage, and the data in Figure 5
support the role of the NER mechanism in protecting cells
from mustard toxicity since firefly luciferase gene damaged
by either SM or CEES is restored to a higher level of expression
in the NER-competent CHO cells. This reinforces the belief
that DNA repair mechanisms protect against SM toxicity.
Thus the host cell reactivation assay described in this
manuscript demonstrates that there is a direct relationship
between resistance to SM and CEES toxicity and the cellular
repair of DNA damage caused by these agents. This not only
validates the hypothesis that DNA damage is the root cause
of mustard toxicity, but provides a method of testing environ-
mental conditions such as hypothermia that may increase the
extent of DNA repair.
13.Matijasevic,Z., Stering,A., Niu,T.-Q., Austin-Ritchie,P. and Ludlum,D.B.
(1996) Release of sulfur mustard-modified DNA bases by E.coli 3-
methyladenine DNA glycosylase II. Carcinogenesis, 17, 2249–2252.
14.Kircher,M., Fleer,R., Ruhland,A. and Brendel,M. (1979) Biological and
chemical effects of mustard gas in yeast. Mutat. Res., 63, 273–289.
15.Dabholkar,M., Eastman,A. and Reed,E. (1990) Host-cell reactivation of
cisplatin-damaged pRSVcat in a human lymphoid cell line. Carcinogenesis,
11, 1761–1764.
16.Ruan,S., Okcu,M.F., Ren,J.P., Chiao,P., Andreeff,M., Levin,V. and
Zhang,W. (1998) Overexpressed WAF1/Cip1 renders glioblastoma cells
resistant to chemotherapy agents 1,3-bis(2-chloroethyl)-1-nitrosourea and
cisplatin. Cancer Res., 58, 1538–1543.
17.Sheibani,N., Jennerwein,M.M. and Eastman,A. (1989) DNA repair in cells
sensitive and resistant to cis-diamminedichloroplatinum(II): Host cell
reactivation of damaged plasmid DNA. Biochemistry, 28, 3120–3124.
18.Yen,L., Woo,A., Christopoulopoulos,G., Bastist,G., Panasci,L., Roy,R.,
Mitra,S. and Alaoui-Jamali,M.A. (1995) Enhanced host cell reactivation
capacity and expression of DNA repair genes in human breast cancer cells
resistant to bi-functional alkylating agents. Mutat. Res., 337, 179–189.
Acknowledgements
This work was supported by the US Army Medical Research and Materiel
Command under Contracts DAMD17-96-C-6073 and DAMD17-00-C-0012.
Received October 25, 2000; revised December 21, 2000;
accepted December 28, 2000
664